News & Updates

Show Multimedia Only

DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults

22 Sep 2022 by

Older adults who receive a high-dose quadrivalent influenza vaccine have a 49 percent reduced risk of death and a 64 percent reduced risk of hospitalization for influenza or pneumonia compared with those who receive a standard-dose vaccine, results of the DANFLU-1 study showed.

22 Sep 2022

Inhaled IFN-β1a shows favourable signals for hospitalized COVID-19 patients

22 Sep 2022 by

In the phase III SPRINTER trial, inhaled interferon-beta-1a (IFN-β1a) showed encouraging signals for preventing disease progression or death in hospitalized COVID-19 patients.

22 Sep 2022

Awake prone positioning helps avoid mechanical ventilation in COVID-19

21 Sep 2022 by

Keeping COVID-19 patients in the prone position even while they are awake appears to reduce the need for invasive mechanical ventilation (IMV), according to a recent Singapore study.

21 Sep 2022

Trichomoniasis infection ups prostate cancer, benign prostate hyperplasia risk

20 Sep 2022 by

Men with Trichomoniasis vaginalis infections appear to be at an elevated risk of prostate cancer (PCa) and benign prostate hyperplasia (BPH), according to a recent study.

20 Sep 2022

Vitamin C infusion in ICU-admitted patients: Any benefit?

18 Sep 2022 by

The administration of intravenous vitamin C to patients with sepsis admitted to the intensive care unit (ICU) did not result in a reduced risk of death or organ dysfunction, according to results of the phase III LOVIT* trial.

18 Sep 2022

Female gout patients at higher risk of SARS-CoV-2 infection, severe sequelae

18 Sep 2022

Despite being vaccinated against COVID-19, women with gout have an excess risk of developing SARS-CoV-2 infection as well as severe sequelae from it, according to a study.

18 Sep 2022

Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection

16 Sep 2022 by

Treatment with vebicorvir (VBR) plus nucleos(t)ide reverse transcriptase inhibitors (NrtIs) among virologically suppressed patients with chronic hepatitis B virus (HBV) is well tolerated and has a favourable safety profile, according to a 24-week study.

16 Sep 2022

Smoking during surgical mask use may impair vascular function

16 Sep 2022 by

Smoking during prolonged use of surgical facemasks due to the COVID-19 pandemic may further compromise vascular function, a study has shown.

16 Sep 2022

Monkeypox now a global health emergency

15 Sep 2022 by

The WHO has declared the monkeypox outbreak a global health emergency – the agency’s highest level of alert – following a worldwide upsurge in cases. There are currently 5 deaths tied to the outbreak – Spain has seen two deaths, India has one, while Brazil and Ecuador have one each. As of the latest reports, cases have crossed 38,800 in 80 countries where monkeypox is not endemic.

15 Sep 2022

Original New Drug Application Approvals by US FDA (01 - 15 September 2022)

15 Sep 2022

New drug applications approved by US FDA as of 01 - 15 September 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

15 Sep 2022

News & Updates

Showing Infectious Diseases articles

Showing

Specialty:

DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults

Inhaled IFN-β1a shows favourable signals for hospitalized COVID-19 patients

Awake prone positioning helps avoid mechanical ventilation in COVID-19

Trichomoniasis infection ups prostate cancer, benign prostate hyperplasia risk

Vitamin C infusion in ICU-admitted patients: Any benefit?

Female gout patients at higher risk of SARS-CoV-2 infection, severe sequelae

Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection

Smoking during surgical mask use may impair vascular function

Monkeypox now a global health emergency

Original New Drug Application Approvals by US FDA (01 - 15 September 2022)